BRAF and colorectal carcinoma: CRC patients with microbiotas enriched for pathogenic bacteria such as Fusobacterium nucleatum (Fn) and Bacteroides fragilis (Bf) generally present distinct phenotypic (frequent association with MSI-H, BRAF mutation, right-sided location) and clinical features (impaired chemotherapy response and poor outcome) [60].